Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Originally published in Science Express on 25 September 2008
Science 7 November 2008:
Vol. 322. no. 5903, pp. 945 - 949
DOI: 10.1126/science.1162494
Prev | Table of Contents | Next

Reports

Induced Pluripotent Stem Cells Generated Without Viral Integration

Matthias Stadtfeld,1,2,4,5 Masaki Nagaya,3,5 Jochen Utikal,1,2,4,5 Gordon Weir,3,5 Konrad Hochedlinger1,2,4,5*

Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome-integrating viruses. We generated mouse induced pluripotent stem (iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc. These adenoviral iPS (adeno-iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient-specific stem cells and for comparing embryonic stem cells and iPS cells.

1 Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine, 185 Cambridge Street, Boston, MA 02114, USA.
2 Harvard Stem Cell Institute, Cambridge, MA 02138, USA.
3 Section on Islet Transplantation and Cell Biology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02115, USA.
4 Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.
5 Department of Medicine, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.

* To whom correspondence should be addressed. E-mail: khochedlinger{at}helix.mgh.harvard.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
C. Li, J. Zhou, G. Shi, Y. Ma, Y. Yang, J. Gu, H. Yu, S. Jin, Z. Wei, F. Chen, et al. (2009)
Hum. Mol. Genet. 18, 4340-4349
   Abstract »    Full Text »    PDF »
Genome 10K: A Proposal to Obtain Whole-Genome Sequence for 10 000 Vertebrate Species.
Genome 10K Community of Scientists (2009)
J. Hered.
   Abstract »    Full Text »    PDF »
Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.
D. S. Kaufman (2009)
Blood 114, 3513-3523
   Abstract »    Full Text »    PDF »
Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells.
L. Zwi, O. Caspi, G. Arbel, I. Huber, A. Gepstein, I.-H. Park, and L. Gepstein (2009)
Circulation 120, 1513-1523
   Abstract »    Full Text »    PDF »
Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells.
J. Utikal, N. Maherali, W. Kulalert, and K. Hochedlinger (2009)
J. Cell Sci. 122, 3502-3510
   Abstract »    Full Text »    PDF »
On the Road to iPS Cell Cardiovascular Applications.
T. J. Kamp and G. E. Lyons (2009)
Circ. Res. 105, 617-619
   Full Text »    PDF »
iPS Programmed Without c-MYC Yield Proficient Cardiogenesis for Functional Heart Chimerism.
A. Martinez-Fernandez, T. J. Nelson, S. Yamada, S. Reyes, A. E. Alekseev, C. Perez-Terzic, Y. Ikeda, and A. Terzic (2009)
Circ. Res. 105, 648-656
   Abstract »    Full Text »    PDF »
Generation of pluripotent stem cells from patients with type 1 diabetes.
R. Maehr, S. Chen, M. Snitow, T. Ludwig, L. Yagasaki, R. Goland, R. L. Leibel, and D. A. Melton (2009)
PNAS 106, 15768-15773
   Abstract »    Full Text »    PDF »
Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells.
N. Sun, N. J. Panetta, D. M. Gupta, K. D. Wilson, A. Lee, F. Jia, S. Hu, A. M. Cherry, R. C. Robbins, M. T. Longaker, et al. (2009)
PNAS 106, 15720-15725
   Abstract »    Full Text »    PDF »
Senescence impairs successful reprogramming to pluripotent stem cells.
A. Banito, S. T. Rashid, J. C. Acosta, S. Li, C. F. Pereira, I. Geti, S. Pinho, J. C. Silva, V. Azuara, M. Walsh, et al. (2009)
Genes & Dev. 23, 2134-2139
   Abstract »    Full Text »    PDF »
Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells.
T. VandenDriessche, Z. Ivics, Z. Izsvak, and M. K. L. Chuah (2009)
Blood 114, 1461-1468
   Abstract »    Full Text »    PDF »
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation.
E. P. Papapetrou, M. J. Tomishima, S. M. Chambers, Y. Mica, E. Reed, J. Menon, V. Tabar, Q. Mo, L. Studer, and M. Sadelain (2009)
PNAS 106, 12759-12764
   Abstract »    Full Text »    PDF »
Repair of Acute Myocardial Infarction by Human Stemness Factors Induced Pluripotent Stem Cells.
T. J. Nelson, A. Martinez-Fernandez, S. Yamada, C. Perez-Terzic, Y. Ikeda, and A. Terzic (2009)
Circulation 120, 408-416
   Abstract »    Full Text »    PDF »
Derivation of induced pluripotent stem cells from pig somatic cells.
T. Ezashi, B. P. V. L. Telugu, A. P. Alexenko, S. Sachdev, S. Sinha, and R. M. Roberts (2009)
PNAS 106, 10993-10998
   Abstract »    Full Text »    PDF »
Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease.
K. D. Boudoulas and A. K. Hatzopoulos (2009)
Dis. Model. Mech. 2, 344-358
   Abstract »    Full Text »    PDF »
Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig.
M. A. Esteban, J. Xu, J. Yang, M. Peng, D. Qin, W. Li, Z. Jiang, J. Chen, K. Deng, M. Zhong, et al. (2009)
J. Biol. Chem. 284, 17634-17640
   Abstract »    Full Text »    PDF »
Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases.
L. Ye, J. C. Chang, C. Lin, X. Sun, J. Yu, and Y. W. Kan (2009)
PNAS 106, 9826-9830
   Abstract »    Full Text »    PDF »
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.
C. A. Lyssiotis, R. K. Foreman, J. Staerk, M. Garcia, D. Mathur, S. Markoulaki, J. Hanna, L. L. Lairson, B. D. Charette, L. C. Bouchez, et al. (2009)
PNAS 106, 8912-8917
   Abstract »    Full Text »    PDF »
Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector.
F. Gonzalez, M. Barragan Monasterio, G. Tiscornia, N. Montserrat Pulido, R. Vassena, L. Batlle Morera, I. Rodriguez Piza, and J. C. I. Belmonte (2009)
PNAS 106, 8918-8922
   Abstract »    Full Text »    PDF »
Cellular reprogramming and pluripotency induction.
M. W. Lensch (2009)
Br. Med. Bull. 90, 19-35
   Abstract »    Full Text »    PDF »
Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences.
J. Yu, K. Hu, K. Smuga-Otto, S. Tian, R. Stewart, I. I. Slukvin, and J. A. Thomson (2009)
Science 324, 797-801
   Abstract »    Full Text »    PDF »
Transcriptome transfer produces a predictable cellular phenotype.
J.-Y. Sul, C.-w. K. Wu, F. Zeng, J. Jochems, M. T. Lee, T. K. Kim, T. Peritz, P. Buckley, D. J. Cappelleri, M. Maronski, et al. (2009)
PNAS 106, 7624-7629
   Abstract »    Full Text »    PDF »
Instructing an Embryonic Stem Cell-Derived Oocyte Fate: Lessons from Endogenous Oogenesis.
C. R. Nicholas, S. L. Chavez, V. L. Baker, and R. A. Reijo Pera (2009)
Endocr. Rev. 30, 264-283
   Abstract »    Full Text »    PDF »
Unique and Overlapping Functions of GSK-3 Isoforms in Cell Differentiation and Proliferation and Cardiovascular Development.
T. Force and J. R. Woodgett (2009)
J. Biol. Chem. 284, 9643-9647
   Abstract »    Full Text »    PDF »
Klf4 reverts developmentally programmed restriction of ground state pluripotency.
G. Guo, J. Yang, J. Nichols, J. S. Hall, I. Eyres, W. Mansfield, and A. Smith (2009)
Development 136, 1063-1069
   Abstract »    Full Text »    PDF »
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells.
J. Zhang, G. F. Wilson, A. G. Soerens, C. H. Koonce, J. Yu, S. P. Palecek, J. A. Thomson, and T. J. Kamp (2009)
Circ. Res. 104, e30-e41
   Abstract »    Full Text »    PDF »
Epigenetic reprogramming and induced pluripotency.
K. Hochedlinger and K. Plath (2009)
Development 136, 509-523
   Abstract »    Full Text »    PDF »
From the Cover: Phenotypic correction of murine hemophilia A using an iPS cell-based therapy.
D. Xu, Z. Alipio, L. M. Fink, D. M. Adcock, J. Yang, D. C. Ward, and Y. Ma (2009)
PNAS 106, 808-813
   Abstract »    Full Text »    PDF »
Reprogramming of murine and human somatic cells using a single polycistronic vector.
B. W. Carey, S. Markoulaki, J. Hanna, K. Saha, Q. Gao, M. Mitalipova, and R. Jaenisch (2009)
PNAS 106, 157-162
   Abstract »    Full Text »    PDF »
Nuclear Reprogramming in Cells.
J. B. Gurdon and D. A. Melton (2008)
Science 322, 1811-1815
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)